| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 0 $ | +0 $ | 1 | 30.523.310 $ | +8.157.006 $ | +19,3 % | 6 | 22.787.545 $ | -92.332.816 $ | +119,8 % | 7 | 115.120.361 $ | +23.512.127 $ | +54,5 % | 7 | |||||
| Arcellx, Inc. | ACLX | → 0 | 25.660.663 $ | +11.089.376 $ | +76,1 % | 1 | 14.571.287 $ | -71.433.143 $ | -83,1 % | 1 | 86.004.430 $ | +17.022.802 $ | +24,7 % | 1 | |||||
| Kymera Therapeutics, Inc. | KYMR | → 0 | Schwach | 1.636.482 $ | +107.671 $ | +7,0 % | 1 | 1.528.811 $ | -24.336.158 $ | -94,1 % | 1 | 25.864.969 $ | +5.918.914 $ | +29,7 % | 1 | ||||
| Rallybio Corp | RLYB | → 0 | Stark | 846.176 $ | -3.296.101 $ | -79,6 % | 1 | 4.142.277 $ | +3.764.938 $ | +997,8 % | 1 | 377.339 $ | +122.258 $ | +47,9 % | 1 | ||||
| Seer, Inc. | SEER | → 0 | Neutral | 1.542.949 $ | +48.983 $ | +3,3 % | 1 | 1.493.966 $ | -310.223 $ | -17,2 % | 1 | 1.804.189 $ | +57.146 $ | +3,3 % | 1 | ||||
| Xilio Therapeutics, Inc. | XLO | → 0 | Stark | 401.115 $ | -26.373 $ | -6,2 % | 1 | 427.488 $ | -168.071 $ | -28,2 % | 1 | 595.559 $ | +141.561 $ | +31,2 % | 1 | ||||
| SUTRO BIOPHARMA, INC. | STRO | → 0 | Neutral | 435.925 $ | +233.450 $ | +115,3 % | 1 | 202.475 $ | +49.350 $ | +32,2 % | 1 | 153.125 $ | +28.192 $ | +22,6 % | 1 | ||||
| RAPT Therapeutics, Inc. | RAPT | → 0 | 421.241 $ | +100.491 $ | +31,3 % | 1 | 320.750 $ | +221.254 $ | +222,4 % | 1 | |||||||||
| HL Scope RIC LLC | → 0 | 0 $ | +0 $ | 1 | |||||||||||||||
| 0 $ | +0 $ | 1 | 30.523.310 $ | +8.157.006 $ | +19,3 % | 6 | 22.787.545 $ | -92.332.816 $ | +119,8 % | 7 | 115.120.361 $ | +23.512.127 $ | +54,5 % | 7 | |||||